Autoimmune glial fibrillary acidic protein astrocytopathy
Conditions
Interventions
Observation group:None
Sponsors
Yuebei People’s Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 72 Years
Inclusion criteria
Inclusion criteria: 1.Positive results of cerebrospinal fluid GFAP-IgG detected by cell-based assay (CBA); 2.The clinical manifestations included at least one of meningitis, encephalitis, myelitis and optic neuritis. 3.Other diseases that could account for the symptoms were ruled out after systematic evaluation. 4.Sufficient and intact clinical information;
Exclusion criteria
Exclusion criteria: 1.Patients complicated with intracranial tumors, central nervous system infections, neurodegenerative diseases, metabolic encephalopathy, toxic encephalopathy, and other types of autoimmune encephalitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delayed diagnosis and misdiagnosis; | — |
Countries
China
Contacts
Public ContactLin Sheng
Yuebei People’s Hospital
Outcome results
None listed